Tran-Scell Biologics Private Limited

Tran-Scell Biologics Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U85100TG2009PTC066172 Incorporated 07 December 2009 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹1.44 Cr
▲ 1134.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹3.22 Cr
Registered with MCA
Paid-up capital
₹3.14 Cr
Issued & subscribed
Open charges
None
Satisfied ₹1.95 Cr
Company age
17 yrs
Est. 2009
Last financials
Mar 2025
Balance sheet date

About Tran-Scell Biologics Private Limited

Data last updated: 22 December 2025

Tran-Scell Biologics Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in diabetes care and endocrinology clinics, a part of the broader healthcare sector. Incorporated on 07 December 2009, the company has been in operation for over 17 years.

Registered with ROC Hyderabad under CIN U85100AP2009PTC066172.

Capital: an authorised share capital of ₹3.22 Cr and a paid-up capital of ₹3.14 Cr. It is led by directors including Uday Chatterjee and Vinayender Tulla.

Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: 8Th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.44 Cr, reflecting significant growth compared to the previous year.

The company is associated with 1 brand - Transcell Biosciences. As per MCA filings, the company has satisfied charges of ₹1.95 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website transcell.in.

Company Details of Tran-Scell Biologics Private Limited
CIN U85100TG2009PTC066172
Registration Number 066172
Incorporation Date 07 December 2009
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    8Th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084
  • Industry
    Healthcare, Diabetes Care & Endocrinology Clinics
Company report
Tran-Scell Biologics Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Tran-Scell Biologics Private Limited report

Financials, compliance, directors, charges, ownership and filings for Tran-Scell Biologics Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Tran-Scell Biologics Private Limited

Tran-Scell Biologics Private Limited has one previous CIN (Corporate Identification Number): U85100AP2009PTC066172. The current CIN is U85100TG2009PTC066172, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U85100TG2009PTC066172 Current
U85100AP2009PTC066172 Previous

Associated Brands with Tran-Scell Biologics Private Limited

Tran-Scell Biologics Private Limited operates one associated brand: Transcell Biosciences. These brands represent Tran-Scell Biologics Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Stem cell banking and biobanking services are provided by Transcell Biosciences. transcell.in

Competitors & Alternatives of Tran-Scell Biologics Private Limited

Brands and companies operating in the same space as Tran-Scell Biologics Private Limited include StemCyte, Forever Labs, China Cord Blood and 4 more.

Competitor Description Location Founded
StemCyte StemCyte Umbilical cord blood stem cell transplantation and therapeutic products company Covina, United States, United States 1997
Forever Labs Forever Labs Stem cells are stored and preserved for future therapeutic applications. Detroit, United States, United States 2015
China Cord Blood China Cord Blood Biobanking services for umbilical cord blood stem cells are provided. Hong Kong, China, China 2003
LaCell LaCell Stem Cell Production New Orleans, United States, United States 2010
Provia Labs Provia Labs Stem cell biobanking and manufacturing from children's teeth are provided. Littleton, United States, United States 2009
Mill Creek Life Sciences Mill Creek Life Sciences Tools and technologies to support the development and application of cellular and biologic therapeutics Rochester, United States, United States 2010
Generate Generate Provider of services for the storage of stem cells Los Angeles, United States, United States 1977

Business Activity of Tran-Scell Biologics Private Limited

Tran-Scell Biologics Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Tran-Scell Biologics Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Tran-Scell Biologics Private Limited

Tran-Scell Biologics Private Limited is currently managed by 4 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Uday Chatterjee Director 11 May 2020 6 Years 2 Months Current
Vinayender Tulla Director 05 Oct 2015 10 Years 9 Months Current
Subhadra Dravida Managing Director 07 Dec 2009 16 Years 7 Months Current
Asif Wahidul Hasan Director 25 Jul 2024 1 Years 11 Months Current

Financials of Tran-Scell Biologics Private Limited FY 2025 filings available

Tran-Scell Biologics Private Limited reported revenue of ₹1.44 Cr (up 1134.00% YoY) for FY 2025.

Revenue · FY 2025
₹1.44 Cr ▲ 1134.00%
Premium access

Ten-year financial statements for Tran-Scell Biologics Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Tran-Scell Biologics Private Limited

Open charges
₹0
Satisfied charges
₹1.95 Cr
Breakdown by lending institutions
Andhra Pradesh State Financial Corporation₹1.55 Cr
Others₹0.40 Cr
Latest charge details
DateLenderAmountStatus
22 Jun 2012 Others ₹40 Lakh Satisfied
21 May 2010 Andhra Pradesh State Financial Corporation ₹1.55 Cr Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Tran-Scell Biologics Private Limited

View historical data on people associated with Tran-Scell Biologics Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Tran-Scell Biologics Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Tran-Scell Biologics Private Limited

Premium access

GST registrations and filing compliance for Tran-Scell Biologics Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Tran-Scell Biologics Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Tran-Scell Biologics Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Tran-Scell Biologics Private Limited

Premium access

MSME payment history for Tran-Scell Biologics Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Tran-Scell Biologics Private Limited

Premium access

Corporate group structure for Tran-Scell Biologics Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Tran-Scell Biologics Private Limited

Premium access

MCA filings and documents for Tran-Scell Biologics Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Tran-Scell Biologics Private Limited

Activity
26 Sep 2025
Tran-Scell Biologics Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Charges
20 Jun 2025
A charge registered on 22 Jun 2012 via Charge ID 10366630 with Others was fully satisfied on 20 Jun 2025.
Activity
31 Mar 2025
Tran-Scell Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
25 Jul 2024
Asif Wahidul Hasan was appointed as a Director on 25 Jul 2024 & has been associated with this company since 1 year 11 months.
Charges
21 Sep 2021
A charge with Others of Rs. 0.40 Cr registered on 22 Jun 2012 with Charge ID 10366630 was modified on 21 Sep 2021.
Directors
11 May 2020
Uday Chatterjee was appointed as a Director on 11 May 2020 & has been associated with this company since 6 years 2 months.

Frequently Asked Questions about Tran-Scell Biologics Private Limited

Tran-Scell Biologics Private Limited is an active private limited company in the healthcare sector based in Hyderabad, Telangana, India. It was incorporated on 07 December 2009 (17+ years old) and is registered under CIN U85100TG2009PTC066172.

Tran-Scell Biologics Private Limited reported revenue of ₹1.44 Cr for FY 2025 (up 1134.00% YoY).

The current directors of Tran-Scell Biologics Private Limited are:

The primary industry of Tran-Scell Biologics Private Limited is healthcare. The company specifically operates in diabetes care and endocrinology clinics. The company is currently active in this sector.

Tran-Scell Biologics Private Limited can be reached at the registered office: 8Th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084, or through the website transcell.in.

The authorised capital is ₹3.22 Cr, and the paid-up capital is ₹3.14 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available